Difference between revisions of "Template:Lipid modifying agents"

From blackwiki
Jump to navigation Jump to search
imported>Anypodetos
m (Bypass redirect)
Line 9: Line 9:
  
 
| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
 
| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]]
|  list1 = [[Ezetimibe]] • [[SCH-48461]]
+
|  list1 = [[Ezetimibe]] • [[SCH-48461]]
  
 
| group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
 
| group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]])
| list2  = [[Cholestyramine]] • [[Colestipol]] • [[Colestilan]] • [[Colextran]] • [[Colesevelam]]
+
| list2  = [[Cholestyramine]] • [[Colestipol]] • [[Colestilan]] • [[Colextran]] • [[Colesevelam]]
  
 
}}
 
}}
Line 22: Line 22:
  
 
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
 
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]])
| list1  = [[Simvastatin]]<sup>#</sup>&nbsp;• [[Atorvastatin]]&nbsp;• [[Fluvastatin]]&nbsp;• [[Lovastatin]]&nbsp;• [[Mevastatin]]&nbsp;• [[Pitavastatin]]&nbsp;• [[Pravastatin]]&nbsp;• [[Rosuvastatin]]&nbsp;• [[Cerivastatin]]<sup>‡</sup>
+
| list1  = [[Simvastatin]]<sup>#</sup>&nbsp;• [[Atorvastatin]]&nbsp;• [[Fluvastatin]]&nbsp;• [[Lovastatin]]&nbsp;• [[Mevastatin]]&nbsp;• [[Pitavastatin]]&nbsp;• [[Pravastatin]]&nbsp;• [[Rosuvastatin]]&nbsp;• [[Cerivastatin]]<sup>‡</sup>
  
 
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
 
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]])
|  list2 = [[Niceritrol]]&nbsp;• [[Niacin]]&nbsp;• [[Nicofuranose]]&nbsp;• [[Aluminium nicotinate]]&nbsp;• [[Nicotinyl alcohol]]&nbsp;• [[Acipimox]]
+
|  list2 = [[Niceritrol]]&nbsp;• [[Niacin]]&nbsp;• [[Nicofuranose]]&nbsp;• [[Aluminium nicotinate]]&nbsp;• [[Nicotinyl alcohol]]&nbsp;• [[Acipimox]]
  
 
}}
 
}}
Line 34: Line 34:
  
 
| group1 =  [[Fibrate]]s ([[PPAR modulator|PPAR]])
 
| group1 =  [[Fibrate]]s ([[PPAR modulator|PPAR]])
| list1  = [[Clofibrate]]<sup>‡</sup>&nbsp;• [[Bezafibrate]]&nbsp;• [[Aluminium clofibrate]]&nbsp;• [[Gemfibrozil]]&nbsp;• [[Fenofibrate]]&nbsp;• [[Simfibrate]]&nbsp;• [[Ronifibrate]]&nbsp;• [[Ciprofibrate]]&nbsp;• [[Etofibrate]]&nbsp;• [[Clofibride]]&nbsp;• [[Clinofibrate]]
+
| list1  = [[Clofibrate]]<sup>‡</sup>&nbsp;• [[Bezafibrate]]&nbsp;• [[Aluminium clofibrate]]&nbsp;• [[Gemfibrozil]]&nbsp;• [[Fenofibrate]]&nbsp;• [[Simfibrate]]&nbsp;• [[Ronifibrate]]&nbsp;• [[Ciprofibrate]]&nbsp;• [[Etofibrate]]&nbsp;• [[Clofibride]]&nbsp;• [[Clinofibrate]]
  
  
 
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
 
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]])
|  list2 = [[Anacetrapib]]<sup>†</sup>&nbsp;• [[Dalcetrapib]]&nbsp;• [[Torcetrapib]]<sup>§</sup>
+
|  list2 = [[Anacetrapib]]<sup>†</sup>&nbsp;• [[Dalcetrapib]]&nbsp;• [[Torcetrapib]]<sup>§</sup>
  
  
Line 46: Line 46:
  
 
| group7 = Combinations
 
| group7 = Combinations
|  list7 = [[Niacin/lovastatin]]&nbsp;• [[Niacin/simvastatin]]&nbsp;• [[Ezetimibe/simvastatin]]&nbsp;• [[Niacin/laropiprant]]
+
|  list7 = [[Niacin/lovastatin]]&nbsp;• [[Niacin/simvastatin]]&nbsp;• [[Ezetimibe/simvastatin]]&nbsp;• [[Laropiprant|Niacin/laropiprant]]
  
 
| group8 = Other
 
| group8 = Other
|  list8 = [[Dextrothyroxine]]&nbsp;• [[Probucol]]&nbsp;• [[Tiadenol]]&nbsp;• [[Benfluorex]]&nbsp;• [[Meglutol]]&nbsp;• [[Omega-3-triglycerides]]&nbsp;• [[Magnesium pyridoxal 5-phosphate glutamate]]&nbsp;• [[Policosanol]]&nbsp;• [[Lapaquistat]]<sup>§</sup>&nbsp;• [[Alipogene tiparvovec]]
+
|  list8 = [[Dextrothyroxine]]&nbsp;• [[Probucol]]&nbsp;• [[Tiadenol]]&nbsp;• [[Benfluorex]]&nbsp;• [[Meglutol]]&nbsp;• [[Omega-3-triglycerides]]&nbsp;• [[Magnesium pyridoxal 5-phosphate glutamate]]&nbsp;• [[Policosanol]]&nbsp;• [[Lapaquistat]]<sup>§</sup>&nbsp;• [[Alipogene tiparvovec]]
  
 
| list9 = {{PharmNavFootnote}}
 
| list9 = {{PharmNavFootnote}}

Revision as of 12:19, 25 July 2011